login
  Password reminder
NeuroNews
Contact the editor Visit NeuroNews Twitter feed Visit NeuroNews Facebook page
 

“The brain is not the heart, but we wish to carry out the same mechanical recovery in brain vessels”


Thursday, 17 May 2012 10:40
Mario Muto
Mario Muto


Mario Muto, Neuroradiology, Antonio Cardarelli Hospital, Naples, Italy, and course director of the Naples Stroke Meeting (18–19 June 2012) tells NeuroNews about the importance of cooperation between diagnostic neurologists and interventional neuroradiologists and that better clinical results can be obtained when medical and endovascular therapy are combined.


As the course director, can you please tell NeuroNews readers what the broad goals of the Naples Stroke meeting are?

There are many differences in the numbers of acute ischaemic stroke patients treated and variations in the type of treatment they receive, from country to country and city to city, and this depends mostly on the different organisation models. Neurologists play a key role in admitting and managing acute ischaemic stroke patients, and for this reason, it is also important to show them the improvements seen in endovascular treatment.


What are the three most important things that a delegate will learn about the latest developments in stroke from the scientific programme of the meeting?


Delegates will learn about the importance of i) the organisation model ii) the importance of co-operation between diagnostic neurologists and interventional neuroradiologists and iii) that better clinical results can be obtained when medical and endovascular therapy are combined.


You are co-ordinating a session on hands-on training on the different devices for endovacular stroke treatment. What are the strengths and weaknesses of the following devices: Trevo; Solitaire; Penumbra, New Catch and Revive?


The concept behind these devices is often similar (with the exception of Penumbra in which there is the additional association of thrombo-aspiration) but probably the radial force of each system is different. Training with these devices and taking into account the learning curve are also important. So far, the experience reported by different centres has evolved along with the improvement of technology, so that the capacity to capture the thrombus has changed in the years. The radial force of the system is important to keep the thrombus within the net of the stent. It is not possible to say in an absolute way at this point if one stent retriever system is superior to another one.


In your view, what are the three interesting papers which have been published recently which have changed stroke management?


There are several published papers and also trials that are still ongoing (such as the Mr CLEAN, Synthesis, IMS III, EFMINT, River III) which have demonstrated, or are setting out to demonstrate, better results of stroke therapy with medical and endovascular therapy, but we lack an accepted randomised controlled trial. Such a trial that is not so easy to organise and perform on this topic.


What is your key message to neurointerventionists in the field regarding endovascular stroke treatment?


We know that the brain is not the heart, but the aspiration to carry out the same mechanical recovery for vessels in the brain is really high.




Add New Comment

Most popular


MR CLEAN: expert opinion
Tuesday, 18 Nov 2014
Since the first presentation of data at the World Stroke Congress, the MR CLEAN trial has sent a ripple across the entire neurointerventional arena, raising questions about the future of stroke ... MR CLEAN: expert opinion

MR CLEAN: Better outcomes with intervention in ischaemic stroke patients
Thursday, 18 Dec 2014
For the first time, the Multicentre randomised clinical trial of endovascular treatment for acute ischaemic stroke in the Netherlands (MR CLEAN) has shown better outcomes in favour of intervention in ... MR CLEAN: Better outcomes with intervention in ischaemic stroke patients

Silk Road Medical unveils data from the ROADSTER trial
Wednesday, 26 Nov 2014
Silk Road Medical’s 30-day outcomes from the ROADSTER IDE study were presented at the Late Breaking Clinical Trials Session at the 2014 Vascular InterVentional Advances Meeting in Las Vegas, with ... Silk Road Medical unveils data from the ROADSTER trial

Features


Impact“ful” moments
Friday, 05 Dec 2014
Once a year, in almost ritualised fashion, the editors of peer-reviewed journals anxiously await publication of the Thomson Reuters Impact Factor. Journals in the “neuro” space are no exception to ... Impact“ful” moments

The changing face of traumatic brain injury: Life beyond the guidelines
Tuesday, 18 Nov 2014
András Büki and Andrew Maas write that despite considerable efforts both in basic and clinical research, there has not been a major breakthrough in the care of the head injured in the last three ... The changing face of traumatic brain injury: Life beyond the guidelines

Profiles


Vladimír Beneš Jr
Tuesday, 30 Sep 2014
Vladimír Beneš Jr is professor and chair at the First Medical School, Charles University, P... Vladimír Beneš Jr

Mauricio Castillo
Monday, 14 Jul 2014
Mauricio Castillo is a professor of Radiology and chief, Division of Neuroradiology, University of N... Mauricio Castillo

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
 
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions